Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 17, 2007
Patent Application Number
10469131
Date Filed
March 11, 2002
Patent Primary Examiner
Patent abstract
The present invention relates to novel peptides which are useful as antagonists of the β2 integrins, to pharmaceutical compositions comprising these peptides, to the use of the novel peptides for the manufacture of pharmaceutical compositions for the treatment of inflammatory diseases and human leukemias and for inhibiting leukocyte cell adhesion and migration in general, to a method for therapeutic or prophylactic treatment of inflammatory diseases and human leukemias and to the use of the novel peptides as β2 integrin antagonists for biochemical isolation and purification procedures in vitro.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
